MAR 25, 2020 6:24 AM PDT

A coronavirus testing kit with glow-in-the-dark Mango?

WRITTEN BY: Tara Fernandez

A group of Canadian researchers is responding to a desperate need for COVID-19 diagnostic kits with their fluorescent imaging technology, known as Mango.

Molecular biologists Peter Unrau and Lena Dolgosheina from Simon Fraser University originally developed the Mango system as a means of visualizing the dynamics of RNA molecules within living cells. Within the cell’s cytoplasm, the primary function of RNA is to convert genetic information stored as DNA into proteins.

Their Mango imaging system can also be used to detect coronaviruses like SARS-CoV-2, the virus that causes COVID-19.

In general, coronaviruses contain unusually large genomes in a single-stranded RNA format, consisting of around 30,000 RNA bases. Surrounding the viral particle is a spherical envelope that is studded with club-shaped spikes, which gives the virus its crown-like appearance, or “corona”.

The imaging platform has an RNA Mango aptamer component, that specifically targets and binds to a brightly glowing fluorescent dye. RNA molecules containing the Mango aptamer are illuminated by the dye, allowing scientists to observe them at high resolution using a fluorescence microscope.

The same technology can be applied to the development of testing kits of COVID-19, with Mango enabling the rapid detection of virus particles with higher sensitivities than many conventional methods.

 

 

“We are using the Mango system as a catalyst, to allow us to not only extend fundamental research questions but also to detect pathogens like the coronavirus, faster and more efficiently,” says Unrau, a professor of molecular biology and biochemistry.

The team has published details of their imaging tool in Nature Communications.



Sources: Nature Communications, SFU News.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 09, 2019
Neuroscience
OCT 09, 2019
Elderly Depression Remains Consistant As Antidepressant Use Doubles
  A new study from the University of East Anglia finds that despite a 2-fold increase in antidepressant use, depression among individuals 65 and older...
NOV 01, 2019
Chemistry & Physics
NOV 01, 2019
Cancer Therapy Agents Inspired by Solar Technology
In a recent study, a group of biomedical researchers at Michigan State University developed a new platform for tweaking light-activated dyes that can enable diagnostic imaging, image-guided s...
NOV 26, 2019
Immunology
NOV 26, 2019
The Immune System's Hand in Toxic Shock
While rare, toxic shock is a dangerous condition that acts fast and can be fatal. A new study identified a new target for treating toxic shock, a component...
NOV 26, 2019
Cannabis Sciences
NOV 26, 2019
Cannabis Provides Relief from Headache and Migraine Pain
Innovative technology allowed researchers to conduct the first-ever study of cannabis use for the treatment of headache and migraine pain in real-time. Wit...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using co...
MAR 23, 2020
Microbiology
MAR 23, 2020
The Loss of a Sense of Smell May be a Major Symptom of COVID-19
The loss of the sense of smell may be a symptom of a COVID-19 infection in people with no other symptoms....
Loading Comments...